INCY PDUFA
Link to PDUFA PR: https://www.businesswire.com/news/home/20211101005269/en/Incyte-Announces-Acceptance-of-NDA-for-Parsaclisib-for-Three-Types-of-Relapsed-or-Refractory-Non-Hodgkin-Lymphomas
Link to PDUFA PR: https://www.businesswire.com/news/home/20211101005269/en/Incyte-Announces-Acceptance-of-NDA-for-Parsaclisib-for-Three-Types-of-Relapsed-or-Refractory-Non-Hodgkin-Lymphomas